7.55 USD
+0.13 (+1.75%)
7.55 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to BVS. BVS was compared to 187 industry peers in the Health Care Equipment & Supplies industry. BVS has a medium profitability rating, but doesn't score so well on its financial health evaluation. BVS is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year BVS was profitable.
In the past year BVS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BVS reported negative net income in multiple years.
BVS had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
BVS has a better Return On Assets (1.11%) than 75.40% of its industry peers.
BVS's Return On Equity of 4.71% is fine compared to the rest of the industry. BVS outperforms 77.01% of its industry peers.
With an excellent Return On Invested Capital value of 6.62%, BVS belongs to the best of the industry, outperforming 80.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.11% | ||
| ROE | 4.71% | ||
| ROIC | 6.62% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BVS has a Profit Margin of 1.39%. This is in the better half of the industry: BVS outperforms 74.33% of its industry peers.
Looking at the Operating Margin, with a value of 8.03%, BVS is in the better half of the industry, outperforming 75.40% of the companies in the same industry.
BVS's Operating Margin has declined in the last couple of years.
BVS has a better Gross Margin (67.76%) than 72.19% of its industry peers.
In the last couple of years the Gross Margin of BVS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.03% | ||
| PM (TTM) | 1.39% | ||
| GM | 67.76% |
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BVS is destroying value.
BVS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BVS has been increased compared to 5 years ago.
The debt/assets ratio for BVS has been reduced compared to a year ago.
2.2 Solvency
BVS has an Altman-Z score of 1.22. This is a bad value and indicates that BVS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BVS (1.22) is comparable to the rest of the industry.
BVS has a debt to FCF ratio of 6.22. This is a slightly negative value and a sign of low solvency as BVS would need 6.22 years to pay back of all of its debts.
BVS has a better Debt to FCF ratio (6.22) than 76.47% of its industry peers.
A Debt/Equity ratio of 1.93 is on the high side and indicates that BVS has dependencies on debt financing.
The Debt to Equity ratio of BVS (1.93) is worse than 80.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | 6.22 | ||
| Altman-Z | 1.22 |
ROIC/WACC0.77
WACC8.55%
2.3 Liquidity
BVS has a Current Ratio of 1.74. This is a normal value and indicates that BVS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BVS (1.74) is worse than 68.45% of its industry peers.
A Quick Ratio of 1.14 indicates that BVS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.14, BVS is doing worse than 71.66% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.14 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 51.28% over the past year.
The earnings per share for BVS have been decreasing by -16.93% on average. This is quite bad
The Revenue has been growing slightly by 1.58% in the past year.
The Revenue has been growing by 11.01% on average over the past years. This is quite good.
EPS 1Y (TTM)51.28%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)1.58%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-0.23%
3.2 Future
BVS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.51% yearly.
BVS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.43% yearly.
EPS Next Y41.83%
EPS Next 2Y31.93%
EPS Next 3Y25.51%
EPS Next 5YN/A
Revenue Next Year0.33%
Revenue Next 2Y3.66%
Revenue Next 3Y4.43%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 12.80, BVS is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of BVS indicates a rather cheap valuation: BVS is cheaper than 90.91% of the companies listed in the same industry.
BVS is valuated cheaply when we compare the Price/Earnings ratio to 26.56, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 9.23 indicates a reasonable valuation of BVS.
Based on the Price/Forward Earnings ratio, BVS is valued cheaply inside the industry as 95.19% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.79, BVS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.8 | ||
| Fwd PE | 9.23 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BVS is valued cheaper than 91.44% of the companies in the same industry.
BVS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BVS is cheaper than 95.72% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.69 | ||
| EV/EBITDA | 9.84 |
4.3 Compensation for Growth
BVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BVS's earnings are expected to grow with 25.51% in the coming years.
PEG (NY)0.31
PEG (5Y)N/A
EPS Next 2Y31.93%
EPS Next 3Y25.51%
5. Dividend
5.1 Amount
No dividends for BVS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
7.55
+0.13 (+1.75%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners74.46%
Inst Owner Change1.06%
Ins Owners2.51%
Ins Owner Change-0.35%
Market Cap624.84M
Revenue(TTM)563.83M
Net Income(TTM)7.82M
Analysts80
Price Target15.3 (102.65%)
Short Float %3.19%
Short Ratio6.1
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.08%
Min EPS beat(2)-0.99%
Max EPS beat(2)29.14%
EPS beat(4)3
Avg EPS beat(4)86.47%
Min EPS beat(4)-0.99%
Max EPS beat(4)239.51%
EPS beat(8)7
Avg EPS beat(8)133.13%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-0.67%
Max Revenue beat(2)0.07%
Revenue beat(4)2
Avg Revenue beat(4)1.04%
Min Revenue beat(4)-0.67%
Max Revenue beat(4)4.79%
Revenue beat(8)6
Avg Revenue beat(8)4.08%
Revenue beat(12)9
Avg Revenue beat(12)2.76%
Revenue beat(16)10
Avg Revenue beat(16)1.33%
PT rev (1m)2.27%
PT rev (3m)2.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.27%
EPS NY rev (1m)3.13%
EPS NY rev (3m)2.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.31%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.8 | ||
| Fwd PE | 9.23 | ||
| P/S | 1.11 | ||
| P/FCF | 11.69 | ||
| P/OCF | 11.15 | ||
| P/B | 3.76 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.84 |
EPS(TTM)0.59
EY7.81%
EPS(NY)0.82
Fwd EY10.84%
FCF(TTM)0.65
FCFY8.56%
OCF(TTM)0.68
OCFY8.97%
SpS6.81
BVpS2.01
TBVpS-2.64
PEG (NY)0.31
PEG (5Y)N/A
Graham Number5.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.11% | ||
| ROE | 4.71% | ||
| ROCE | 8.38% | ||
| ROIC | 6.62% | ||
| ROICexc | 7.18% | ||
| ROICexgc | 31.69% | ||
| OM | 8.03% | ||
| PM (TTM) | 1.39% | ||
| GM | 67.76% | ||
| FCFM | 9.48% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y44.62%
ROICexgc growth 5Y-8.7%
ROICexc growth 3Y36.86%
ROICexc growth 5Y-12.41%
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
F-Score8
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | 6.22 | ||
| Debt/EBITDA | 3.44 | ||
| Cap/Depr | 5.36% | ||
| Cap/Sales | 0.45% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 60.26% | ||
| Profit Quality | 683.69% | ||
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 1.22 |
F-Score8
WACC8.55%
ROIC/WACC0.77
Cap/Depr(3y)9.96%
Cap/Depr(5y)13.06%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.28%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y41.83%
EPS Next 2Y31.93%
EPS Next 3Y25.51%
EPS Next 5YN/A
Revenue 1Y (TTM)1.58%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-0.23%
Revenue Next Year0.33%
Revenue Next 2Y3.66%
Revenue Next 3Y4.43%
Revenue Next 5YN/A
EBIT growth 1Y178.93%
EBIT growth 3Y6.82%
EBIT growth 5Y-5.11%
EBIT Next Year16.21%
EBIT Next 3Y12.52%
EBIT Next 5YN/A
FCF growth 1Y29806.1%
FCF growth 3Y34.24%
FCF growth 5Y-0.3%
OCF growth 1Y448.75%
OCF growth 3Y19.05%
OCF growth 5Y-0.96%
BIOVENTUS INC - A / BVS FAQ
Can you provide the ChartMill fundamental rating for BIOVENTUS INC - A?
ChartMill assigns a fundamental rating of 5 / 10 to BVS.
What is the valuation status of BIOVENTUS INC - A (BVS) stock?
ChartMill assigns a valuation rating of 8 / 10 to BIOVENTUS INC - A (BVS). This can be considered as Undervalued.
Can you provide the profitability details for BIOVENTUS INC - A?
BIOVENTUS INC - A (BVS) has a profitability rating of 5 / 10.
How financially healthy is BIOVENTUS INC - A?
The financial health rating of BIOVENTUS INC - A (BVS) is 3 / 10.
What is the earnings growth outlook for BIOVENTUS INC - A?
The Earnings per Share (EPS) of BIOVENTUS INC - A (BVS) is expected to grow by 41.83% in the next year.